Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.69p
   
  • Change Today:
    -0.32p
  • 52 Week High: 18.00
  • 52 Week Low: 7.69
  • Currency: UK Pounds
  • Shares Issued: 518.37m
  • Volume: 6,234
  • Market Cap: £39.84m
  • Beta: 0.53

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

Key Personnel

CEO: Carolyn Cross
Chairman: Jean Charest
Chief Technology Officer: Nicolas Loebel
Independent Non-Executive Director: Junaid Bajwa
Senior Independent Non-Executive Director: Jean Duvall
Non-Executive Dir:

Contact Details

Address: 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6
Phone: +1 604 669 0555
Website: https://ondinebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: CA68234M2058

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 7.69p
Change Today -0.32p
% Change -3.94 %
52 Week High 18.00
52 Week Low 7.69
Volume 6,234
Shares Issued 518.37m
Market Cap £39.84m
Beta 0.53

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.11% below the market average70.11% below the market average70.11% below the market average70.11% below the market average70.11% below the market average
95.12% below the sector average95.12% below the sector average95.12% below the sector average95.12% below the sector average95.12% below the sector average
Price Trend
76.81% above the market average76.81% above the market average76.81% above the market average76.81% above the market average76.81% above the market average
95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average
Income Not Available
Growth
41.68% above the market average41.68% above the market average41.68% above the market average41.68% above the market average41.68% above the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average

OBI Dividends

No dividends found

Trades for 15-Jan-2026

Time Volume / Share Price
09:57 6,234 @ 8.02p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page